The variable but inevitable loss of beta cells in overt type 1 diabetes

Pediatric Diabetes

Volumn 4, Issue 1, 2003, Pages 1-3

  Rosenbloom, Arlan L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C PEPTIDE; CYCLOSPORIN A; GLUCOSE; HEMOGLOBIN A1C; INSULIN; NICOTINAMIDE; STEROID;

AUTOIMMUNITY; CELL LOSS; CELL SECRETION; CHILD; CLINICAL FEATURE; DIABETIC KETOACIDOSIS; DIABETIC RETINOPATHY; DISEASE SEVERITY; EDITORIAL; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOGENETICS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; JUVENILE DIABETES MELLITUS; MATURITY ONSET DIABETES MELLITUS; METABOLIC REGULATION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATIENT EDUCATION; PRIORITY JOURNAL; SIDE EFFECT;

ADOLESCENT; ADULT; C-PEPTIDE; CHILD; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISLETS OF LANGERHANS;

EID: 0038445218     PISSN: 1399543X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5448.2003.00005.x     Document Type: Editorial

References (26)

1. KOLB H, GALE EAM. Does partial preservation of residual beta-cell function justify immune intervention in recent onset type 1 diabetes? Diabetologia, 2001: 44: 1349-1353.
2. ROSENBLOOM AL, SCHATZ DA, KRISCHER JP et al. Therapeutic controversy: Prevention and treatment of diabetes in children. J Clin Endocrinol Metab 2000: 85: 494-522.
3. PIETROPAOLO M, BECKER DJ, LIPTON RB. Point/counterpoint - Diabetes prediction/prevention trials in children: is now the time? Pediatr Diabetes 2001: 2: 2-16.
4. KOMULAINEN J, KNIP M, LOUNAMAA R et al. Poor beta cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes Finland Study Group. Diabet Med 1997: 14: 532-537.
5. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP. Effect of intensive therapy on residual beta cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized controlled trial. Ann Intern Med 1998: 128: 517-523.
6. KLEIN R, KLEIN BE, MOSS SE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy. Diabetes 1995: 44: 796-801.
7. MADSBAD S, FABER OK, BINDER C et al. Prevalence of residual beta cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes. Diabetes 1978: 27(Suppl. 1): 262-264.
8. MADSBAD S, KRARUP T, FABER OK, BINDER C, REGEUR L. The transient effect of strict glycaemic control on B cell function in newly diagnosed type 1 (insulin dependent) diabetic patients. Diabetologia 1982: 22: 16-20.
9. DORCHY H, DESPONTIN M, HAUMONT D, TOUSSAINT D, LOEB H. Sécrétion résiduelle d'insuline chez les jeunes diabétiques. Relations avec la durée du diabète, le controle métabolique et la rétinopathie. Arch Fr Pediatr 1982: 39: 145-148.
10. KNIP M, PUUKKA R, KAAR MI, AKERBLOM HK. Remission phase, endogenous insulin secretion and metabolic control in diabetic children. Acta Diabetol Lat 1982: 19: 243-251.
11. AGNER T, DAMM P, BINDER C. Remission in IDDM. prospective study of basal C-peptide and insulin dose in 268 consecutive patients. Diabetes Care 1987: 10: 164-169.
12. SJOBERG S, GUNNARSSON R, GJOTTERBERG M et al. Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987: 30: 208-213.
13. SOCHETT EB, DANEMAN D, CLARSON C, EHRLICH RM. Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children. Diabetologia 1987: 30: 453-459.
14. DANEMAN D, CLARSON C. Residual beta cell function in children with type 1 diabetes: measurement and impact on glycemic control. Clin Invest Med 1987: 10: 484-487.
15. SCHIFFRIN A, SUISSA S, POUSSIER P, GUTTMAN R, WEITZNER G. Prospective study of predictors of beta cell survival in type 1 diabetes. Diabetes 1988: 37: 920-925.
16. MANNA R, SALVATORE M, SCUDERI F et al. Negative correlation between ICA persistence and beta cell restoration after IDDM diagnosis. Diabetes Res 1988: 9: 101-103.
17. PEIG M, GOMIS R, ERCILLA G et al. Correlation between residual beta cell function and islet cell antibodies in newly diagnosed type 1 diabetes. Follow-up study. Diabetes 1989: 38: 1396-1401.
18. COUPER JJ, HUDSON I, WERTHER GA et al. Factors predicting residual beta cell function in the first year after diagnosis of childhood type 1 diabetes. Diabetes Res Clin Pract 1991: 11: 9-16.
19. MONTANA E, FERNANDEZ-CASTANER M, ROSEL P, GOMEZ J, SOLER J. Age, sex and ICA influence on beta cell secretion during the first year after the diagnosis of type 1 diabetes mellitus. Diabetes Metab 1991: 17: 460-468.
20. MARTIN S, PAWLOWSKI B, GREULICH B et al. Natural history of remission in IDDM during first year after diagnosis. Diabetes Care 1992: 15: 66-74.
21. SCHIFFRIN A, SUISSA S, WEITZNER G, POUSSIER P, LALLA D. Factors predicting course of beta cell function in IDDM. Diabetes Care 1992: 15: 997-1001.
22. SNORGAARD O, LASSEN LH, BINDER C. Homogeneity in pattern of decline of beta cell function in IDDM. Prospective study of 204 consecutive cases followed for 7.4 yr. Diabetes Care 1992: 15: 1009-1013.
23. FERNANDEZ-CASTAÑER M, MONTAÑA E, CAMPS I et al. Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes. Diabetes Metab 1996: 22: 349-355.
24. KOMULAINEN J, LOUNAMAA R, KNIP M, KAPRIO EA, ÅKERBLOM HK. The Childhood Diabetes in Finland Study Group. Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Arch Dis Child 1996: 75: 410-415.
25. MONTAÑYA E, FERNANDEZ-CASTAÑER M, SOLER J. Improved metabolic control preserved beta-cell function two years after diagnosis of insulin-dependent diabetes mellitus. Diabetes Metab 1997: 23: 314-319.
26. BONFANTI R, BAZZIGALUPPI E, CALORI G et al. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with type 1 diabetes mellitus. Diabet Med 1998: 15: 844-850.